The Weizmann Institute of Science in Rehovot, Israel, has devised a
noninvasive technique for diagnosing whether a tumour is benign or malignant. A
contrast-enhancing dye is injected into the patient’s bloodstream and magnetic
resonance imaging is used to watch it pass through the tumour. The spaces
between cells and the presence or absence of blood vessels determine the rate at
which the dye passes through. In benign tumours the dye accumulates and washes
out slowly, but in malignant cancers it passes straight through.
More from New 精东传媒
Explore the latest news, articles and features
Popular articles
Trending New 精东传媒 articles
1
Photos reveal unexpected details from the world's first atomic test
2
How I used psychology to come back from the worst year of my life
3
The Selfish Gene at 50: Why Dawkins鈥檚 evolution classic still holds up
4
Can we harness quantum effects to create a new kind of healthcare?
5
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
6
Why your brain needs plenty of 鈥淎ha!鈥 moments
7
The 3 things you need to know about protein, according to an expert
8
The 鈥榙oomsday鈥 glacier鈥檚 giant ice shelf is about to break away
9
The ancient Goths were an ethnically diverse group
10
Human heads have changed shape a lot in the past 100 years
